Clinical Trials List
Protocol NumberNN7769-4514
Completed
2021-12-02 - 2025-04-11
Phase III
Not yet recruiting1
Terminated1
ICD-10D66
Hereditary factor VIII deficiency
ICD-9286.0
Congenital factor VIII disorder
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Principal Investigator
JIAAN-DER WANG
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
267 participants
